Defining Mesenchymal Stem Cell (MSC) and Stromal Cells (SC) Within the cellular Stromal Vascular Fraction (cSVF) of Adipose Tissue Complex: Clarifying Definitions, Characterization and Clinical Significance in Biocellular Regenerative Medicine
Journal of Regenerative Medicine and Biology Research · 11.08.2026 · 7 (2) · 1-6
DOI: 10.46889/jrmbr.2026.7208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Regenerative Medicine and Biology Research, online erschienen am 11.08.2026. Verfasst von Robert W Alexander. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Background
The cellular Stromal Vascular Fraction (cSVF) of adipose tissue is a heterogeneous, uncultured population of nucleated cells that has become central to Biocellular Regenerative Medicine. Within this compartment, the terms “Mesenchymal Stem Cell (MSC)” and “stromal cell” are frequently used interchangeably in both clinical and investigational literature, obscuring an important biological and regulatory distinction.
Objective
This review clarifies the definitional boundary between MSCs and the broader stromal cell population within cSVF, synthesizes consensus phenotypic criteria and examines the clinical significance of this hierarchy for Regenerative practice.
Methods
A narrative synthesis of foundational and contemporary peer-reviewed literature was performed, incorporating the International Society for Cellular Therapy (ISCT) and International Federation for Adipose Therapeutics and Science (IFATS) consensus position statements, primary immunophenotypic studies and clinical series describing cSVF-based Biocellular therapies.
Results
MSCs represent a multipotent subset of the stromal compartment, defined in cultured form by ISCT minimal criteria (plastic adherence, CD105/CD73/CD90 positivity with CD45/CD34/CD14/CD11b/CD79a/CD19/HLA-DR negativity and trilineage differentiation) and, in their native uncultured state within cSVF, by perivascular identity as pericytes (CD146+) and adventitial cells (CD34+). “Stromal cells” constitute the broader IFATS/ISCT-defined umbrella population that additionally includes fibroblasts, preadipocytes, smooth muscle cells and lineage-committed progenitors lacking full multipotency. Beyond differentiation capacity, both MSCs and non-MSC stromal elements contribute substantially through paracrine secretion of growth factors, cytokines and extracellular vesicles, which underlies much of the observed clinical benefit in cSVF- and Platelet-Rich Plasma (PRP)-based Regenerative applications.
Conclusion
Precise, consensus-based terminology distinguishing MSCs from the broader stromal cell population is essential for reproducible cSVF characterization, accurate reporting of clinical outcomes and continued translational advancement of Biocellular Regenerative Medicine.
Zitieren
APA
Alexander, R. W. (2026). Defining Mesenchymal Stem Cell (MSC) and Stromal Cells (SC) Within the cellular Stromal Vascular Fraction (cSVF) of Adipose Tissue Complex: Clarifying Definitions, Characterization and Clinical Significance in Biocellular Regenerative Medicine. Journal of Regenerative Medicine and Biology Research, 7(2), 1-6. https://doi.org/10.46889/jrmbr.2026.7208
Vancouver
Alexander RW. Defining Mesenchymal Stem Cell (MSC) and Stromal Cells (SC) Within the cellular Stromal Vascular Fraction (cSVF) of Adipose Tissue Complex: Clarifying Definitions, Characterization and Clinical Significance in Biocellular Regenerative Medicine. Journal of Regenerative Medicine and Biology Research. 2026;7(2):1-6. doi:10.46889/jrmbr.2026.7208
BibTeX
@article{Alexander2026,
author = {Alexander, Robert W},
title = {Defining Mesenchymal Stem Cell (MSC) and Stromal Cells (SC) Within the cellular Stromal Vascular Fraction (cSVF) of Adipose Tissue Complex: Clarifying Definitions, Characterization and Clinical Significance in Biocellular Regenerative Medicine},
journal = {Journal of Regenerative Medicine and Biology Research},
year = {2026},
volume = {7},
number = {2},
pages = {1--6},
doi = {10.46889/jrmbr.2026.7208}
}
EUVIMED